In a study from Seoul, South Korea, researchers note a higher incidence of Alzheimer’s disease and mild cognitive impairment in people vaccinated against covid-19
“Preliminary evidence suggests a possible association between covid-19 vaccination, especially mRNA vaccines, and increased incidence of AD and MCI”, they write.
A group of South Korean researchers note that there are many questions and challenges associated with covid-19 – not the least of which are widespread concerns about serious vaccine injuries and side effects associated with the experimental mRNA vaccines – including possible links to neurodegenerative diseases such as Alzheimer’s.
A study analyzing data from over 558,000 individuals in the capital city of Seoul sought to investigate the association between covid-19 vaccinations and the onset of Alzheimer’s disease and mild cognitive impairment (MCI).
The data reviewed came from the country’s National Health Insurance Service, and participants were divided into vaccinated and unvaccinated groups, focusing on the incidence of Alzheimer’s disease and MCI after vaccination.
More research needed
The results showed an increased incidence of both MCI and Alzheimer’s disease in vaccinated individuals – and especially in those who received the mRNA vaccine – within three months of vaccination. The mRNA vaccine group showed a significantly higher incidence of Alzheimer’s disease and mild cognitive impairment compared to the unvaccinated group, while no clear association was found between the vaccine and vascular dementia or Parkinson’s disease.
“Preliminary evidence suggests a potential link between covid-19 vaccination, particularly mRNA vaccines, and increased incidences of AD and MCI”, the researchers conclude.
They emphasize that further research is needed “to elucidate the relationship between vaccine-induced immune responses and neurodegenerative processes” and that it is very important that the “vaccines’ long-term neurological impacts” be monitored and studied.
